Bioactive Compounds Targeting Neurodegenerative Diseases

Bioactive Compounds Targeting Neurodegenerative Diseases explores the therapeutic potential of natural bioactive compounds in preventing and managing neurodegenerative disorders such as Alzheimer's, Parkinson’s, and Huntington’s disease. The book integrates insights from neuroscience, pharmacognosy, and nanotechnology to highlight innovative strategies for drug delivery and treatment. Chapters cover plant-based bioactives, advanced nano-carriers, intranasal administration, and blood-brain barrier targeting. It also discusses clinical approaches, current treatment challenges, and intellectual property considerations. Key Features: - Comprehensive overview of natural bioactive compounds in neurodegenerative therapy. - Coverage of phytochemicals, nano-delivery systems, and intranasal administration. - Insights into the blood-brain barrier and clinical management strategies. - Discussion on current therapies and intellectual property issues. Readership: This resource is ideal for researchers, clinicians, and professionals seeking cutting-edge approaches to neurodegenerative disease management.Bioactive Compounds Targeting Neurodegenerative Diseases explores the therapeutic potential of natural bioactive compounds in preventing and managing neurodegenerative disorders such as Alzheimer's, Parkinson’s, and Huntington’s disease. The book integrates insights from neuroscience, pharmacognosy, and nanotechnology to highlight innovative strategies for drug delivery and treatment. Chapters cover plant-based bioactives, advanced nano-carriers, intranasal administration, and blood-brain barrier targeting. It also discusses clinical approaches, current treatment challenges, and intellectual property considerations. Key Features: - Comprehensive overview of natural bioactive compounds in neurodegenerative therapy. - Coverage of phytochemicals, nano-delivery systems, and intranasal administration. - Insights into the blood-brain barrier and clinical management strategies. - Discussion on current therapies and intellectual property issues. Readership: This resource is ideal for researchers, clinicians, and professionals seeking cutting-edge approaches to neurodegenerative disease management.